198 related articles for article (PubMed ID: 21390327)
41. Nuclear transport of Wilms' tumour protein Wt1 involves importins α and β.
Depping R; Schindler SG; Jacobi C; Kirschner KM; Scholz H
Cell Physiol Biochem; 2012; 29(1-2):223-32. PubMed ID: 22415091
[TBL] [Abstract][Full Text] [Related]
42. Transcription of nephrin-Neph3 gene pair is synergistically activated by WT1 and NF-κB and silenced by DNA methylation.
Ristola M; Arpiainen S; Saleem MA; Holthöfer H; Lehtonen S
Nephrol Dial Transplant; 2012 May; 27(5):1737-45. PubMed ID: 21980157
[TBL] [Abstract][Full Text] [Related]
43. The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells.
Dougherty GW; Jose C; Gimona M; Cutler ML
Eur J Cell Biol; 2008 Sep; 87(8-9):721-34. PubMed ID: 18436335
[TBL] [Abstract][Full Text] [Related]
44. Novel replication inhibitory function of the developmental regulator/transcription repressor protein WT1 encoded by the Wilms' tumor gene.
Anant S; Axenovich SA; Madden SL; Rauscher FJ; Subramanian KN
Oncogene; 1994 Nov; 9(11):3113-26. PubMed ID: 7936634
[TBL] [Abstract][Full Text] [Related]
45. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
46. Functional domains of the TGF-beta-inducible transcription factor Tieg3 and detection of two putative nuclear localization signals within the zinc finger DNA-binding domain.
Spittau B; Wang Z; Boinska D; Krieglstein K
J Cell Biochem; 2007 Jun; 101(3):712-22. PubMed ID: 17252542
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.
Maheswaran S; Englert C; Zheng G; Lee SB; Wong J; Harkin DP; Bean J; Ezzell R; Garvin AJ; McCluskey RT; DeCaprio JA; Haber DA
Genes Dev; 1998 Apr; 12(8):1108-20. PubMed ID: 9553041
[TBL] [Abstract][Full Text] [Related]
48. Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.
Li TS; Chen L; Wang SC; Yang YZ; Xu HJ; Gu HM; Zhao XJ; Dong P; Pan Y; Shang ZQ; Zhang XQ; Kong LD
Biochem Pharmacol; 2019 Aug; 166():139-152. PubMed ID: 31085161
[TBL] [Abstract][Full Text] [Related]
49. The decreases of nephrin and nuclear WT1 in podocytes may cause albuminuria during the experimental sepsis in mice.
Kato T; Mizuno S; Kamimoto M
Biomed Res; 2010 Dec; 31(6):363-9. PubMed ID: 21187647
[TBL] [Abstract][Full Text] [Related]
50. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1.
Matsuzawa-Watanabe Y; Inoue J; Semba K
Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737
[TBL] [Abstract][Full Text] [Related]
51. Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.
Ettou S; Jung YL; Miyoshi T; Jain D; Hiratsuka K; Schumacher V; Taglienti ME; Morizane R; Park PJ; Kreidberg JA
Sci Adv; 2020 Jul; 6(30):eabb5460. PubMed ID: 32754639
[TBL] [Abstract][Full Text] [Related]
52. The speckling domain of the Wilms tumor suppressor WT1 overlaps with the transcriptional repression domain.
Herzer U; Lutz B; Hartmann K; Englert C
FEBS Lett; 2001 Apr; 494(1-2):69-73. PubMed ID: 11297737
[TBL] [Abstract][Full Text] [Related]
53. The Wilms' tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling.
Vajjhala PR; Macmillan E; Gonda T; Little M
FEBS Lett; 2003 Nov; 554(1-2):143-8. PubMed ID: 14596929
[TBL] [Abstract][Full Text] [Related]
54. Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes.
Verouti SN; Tsilibary EC; Fragopoulou E; Iatrou C; Demopoulos CA; Charonis AS; Charonis SA; Drossopoulou GI
Nephron Exp Nephrol; 2012; 122(1-2):36-50. PubMed ID: 23548800
[TBL] [Abstract][Full Text] [Related]
55. Despite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210.
Olsson M; English MA; Mason J; Licht JD; Ekblom P
J Negat Results Biomed; 2004 Dec; 3():7. PubMed ID: 15613247
[TBL] [Abstract][Full Text] [Related]
56. A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis.
Benetti E; Caridi G; Malaventura C; Dagnino M; Leonardi E; Artifoni L; Ghiggeri GM; Tosatto SC; Murer L
Clin J Am Soc Nephrol; 2010 Apr; 5(4):698-702. PubMed ID: 20150449
[TBL] [Abstract][Full Text] [Related]
57. PINCH1 plays an essential role in early murine embryonic development but is dispensable in ventricular cardiomyocytes.
Liang X; Zhou Q; Li X; Sun Y; Lu M; Dalton N; Ross J; Chen J
Mol Cell Biol; 2005 Apr; 25(8):3056-62. PubMed ID: 15798193
[TBL] [Abstract][Full Text] [Related]
58. The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway.
Marcet-Palacios M; Ulanova M; Duta F; Puttagunta L; Munoz S; Gibbings D; Radomski M; Cameron L; Mayers I; Befus AD
J Immunol; 2007 Jul; 179(1):256-65. PubMed ID: 17579045
[TBL] [Abstract][Full Text] [Related]
59. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
60. Enhanced podocalyxin expression alters the structure of podocyte basal surface.
Economou CG; Kitsiou PV; Tzinia AK; Panagopoulou E; Marinos E; Kershaw DB; Kerjaschki D; Tsilibary EC
J Cell Sci; 2004 Jul; 117(Pt 15):3281-94. PubMed ID: 15226400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
